Literature DB >> 32878893

A Novel Human Skin Tissue Model To Study Varicella-Zoster Virus and Human Cytomegalovirus.

Megan G Lloyd1, Nicholas A Smith1, Michael Tighe2, Kelsey L Travis2, Dongmei Liu1, Prashant K Upadhyaya3, Paul R Kinchington4, Gary C Chan1, Jennifer F Moffat5.   

Abstract

The herpesviruses varicella-zoster virus (VZV) and human cytomegalovirus (HCMV) are endemic to humans. VZV causes varicella (chicken pox) and herpes zoster (shingles), while HCMV causes serious disease in immunocompromised patients and neonates. More effective, less toxic antivirals are needed, necessitating better models to study these viruses and evaluate antivirals. Previously, VZV and HCMV models used fetal tissue; here, we developed an adult human skin model to study VZV and HCMV in culture and in vivo While VZV is known to grow in skin, it was unknown whether skin could support an HCMV infection. We used TB40/E HCMV and POka VZV strains to evaluate virus tropism in skin organ culture (SOC) and skin xenograft mouse models. Adult human skin from reduction mammoplasties was prepared for culture on NetWells or mouse implantation. In SOC, VZV infected the epidermis and HCMV infected the dermis. Specifically, HCMV infected fibroblasts, endothelial cells, and hematopoietic cells, with some infected cells able to transfer infection. VZV and HCMV mouse models were developed by subcutaneous transplantation of skin into SCID/beige or athymic nude mice at 2 independent sites. Viruses were inoculated directly into one xenograft, and widespread infection was observed for VZV and HCMV. Notably, we detected VZV- and HCMV-infected cells in the contralateral, uninoculated xenografts, suggesting dissemination from infected xenografts occurred. For the first time, we showed HCMV successfully grows in adult human skin, as does VZV. Thus, this novel system may provide a much-needed preclinical small-animal model for HCMV and VZV and, potentially, other human-restricted viruses.IMPORTANCE Varicella-zoster virus and human cytomegalovirus infect a majority of the global population. While they often cause mild disease, serious illness and complications can arise. Unfortunately, there are few effective drugs to treat these viruses, and many are toxic. To complicate this, these viruses are restricted to replication in human cells and tissues, making them difficult to study in traditional animal models. Current models rely heavily on fetal tissues, can be prohibitively expensive, and are often complicated to generate. While fetal tissue models provide helpful insights, it is necessary to study human viruses in human tissue systems to fully understand these viruses and adequately evaluate novel antivirals. Adult human skin is an appropriate model for these viruses because many target cells are present, including basal keratinocytes, fibroblasts, dendritic cells, and lymphocytes. Skin models, in culture and xenografts in immunodeficient mice, have potential for research on viral pathogenesis, tissue tropism, dissemination, and therapy.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  SCID-Hu mouse; crawl-out assay; flow cytometry; histology; human cytomegalovirus; skin organ culture; varicella-zoster virus

Mesh:

Substances:

Year:  2020        PMID: 32878893      PMCID: PMC7592229          DOI: 10.1128/JVI.01082-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium.

Authors:  Cornelia L Trimble; Rachael A Clark; Christopher Thoburn; Nicole C Hanson; Jodie Tassello; Denise Frosina; Ferdynand Kos; Jessica Teague; Ying Jiang; Nicole C Barat; Achim A Jungbluth
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

Review 2.  Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model.

Authors:  Chia-Chi Ku; Jaya Besser; Allison Abendroth; Charles Grose; Ann M Arvin
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

3.  Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy individuals.

Authors:  Maria M Klicznik; Peter A Morawski; Barbara Höllbacher; Suraj R Varkhande; Samantha J Motley; Leticia Kuri-Cervantes; Eileen Goodwin; Michael D Rosenblum; S Alice Long; Gabriele Brachtl; Thomas Duhen; Michael R Betts; Daniel J Campbell; Iris K Gratz
Journal:  Sci Immunol       Date:  2019-07-05

4.  Replication of varicella-zoster virus in human skin organ culture.

Authors:  Shannon L Taylor; Jennifer F Moffat
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in vivo and in vitro.

Authors:  Elisabeth A Pitt; Pranay Dogra; Ravi S Patel; Angela Williams; Jonathan S Wall; Tim E Sparer
Journal:  Antiviral Res       Date:  2016-09-25       Impact factor: 5.970

6.  β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.

Authors:  Chandrav De; Dongmei Liu; Bo Zheng; Uma S Singh; Satish Chavre; Catherine White; Robert D Arnold; Fred K Hagen; Chung K Chu; Jennifer F Moffat
Journal:  Antiviral Res       Date:  2014-07-19       Impact factor: 5.970

7.  Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system.

Authors:  Zhen Zhang; Jenny Rowe; Weijia Wang; Marvin Sommer; Ann Arvin; Jennifer Moffat; Hua Zhu
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

8.  Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow.

Authors:  D von Laer; U Meyer-Koenig; A Serr; J Finke; L Kanz; A A Fauser; D Neumann-Haefelin; W Brugger; F T Hufert
Journal:  Blood       Date:  1995-12-01       Impact factor: 22.113

9.  Circulating T cell-monocyte complexes are markers of immune perturbations.

Authors:  Julie G Burel; Mikhail Pomaznoy; Cecilia S Lindestam Arlehamn; Daniela Weiskopf; Ricardo da Silva Antunes; Yunmin Jung; Mariana Babor; Veronique Schulten; Gregory Seumois; Jason A Greenbaum; Sunil Premawansa; Gayani Premawansa; Ananda Wijewickrama; Dhammika Vidanagama; Bandu Gunasena; Rashmi Tippalagama; Aruna D deSilva; Robert H Gilman; Mayuko Saito; Randy Taplitz; Klaus Ley; Pandurangan Vijayanand; Alessandro Sette; Bjoern Peters
Journal:  Elife       Date:  2019-06-25       Impact factor: 8.140

Review 10.  Current In Vivo Models of Varicella-Zoster Virus Neurotropism.

Authors:  Ravi Mahalingam; Anne Gershon; Michael Gershon; Jeffrey I Cohen; Ann Arvin; Leigh Zerboni; Hua Zhu; Wayne Gray; Ilhem Messaoudi; Vicki Traina-Dorge
Journal:  Viruses       Date:  2019-05-31       Impact factor: 5.048

View more
  9 in total

1.  A Human Skin Model for Assessing Arboviral Infections.

Authors:  Allen T Esterly; Megan G Lloyd; Prashant Upadhyaya; Jennifer F Moffat; Saravanan Thangamani
Journal:  JID Innov       Date:  2022-04-12

Review 2.  The Biology of Varicella-Zoster Virus Replication in the Skin.

Authors:  Cristina Tommasi; Judith Breuer
Journal:  Viruses       Date:  2022-05-06       Impact factor: 5.818

3.  Mutagenesis of the Varicella-Zoster Virus Genome Demonstrates That VLT and VLT-ORF63 Proteins Are Dispensable for Lytic Infection.

Authors:  Shirley E Braspenning; Robert Jan Lebbink; Daniel P Depledge; Claudia M E Schapendonk; Laura A Anderson; Georges M G M Verjans; Tomohiko Sadaoka; Werner J D Ouwendijk
Journal:  Viruses       Date:  2021-11-16       Impact factor: 5.818

4.  Antiviral Targeting of Varicella Zoster Virus Replication and Neuronal Reactivation Using CRISPR/Cas9 Cleavage of the Duplicated Open Reading Frames 62/71.

Authors:  Betty W Wu; Michael B Yee; Ronald S Goldstein; Paul R Kinchington
Journal:  Viruses       Date:  2022-02-12       Impact factor: 5.818

5.  Development of Robust Varicella Zoster Virus Luciferase Reporter Viruses for In Vivo Monitoring of Virus Growth and Its Antiviral Inhibition in Culture, Skin, and Humanized Mice.

Authors:  Megan G Lloyd; Michael B Yee; Joseph S Flot; Dongmei Liu; Brittany W Geiler; Paul R Kinchington; Jennifer F Moffat
Journal:  Viruses       Date:  2022-04-15       Impact factor: 5.818

6.  A Variant Allele in Varicella-Zoster Virus Glycoprotein B Selected during Production of the Varicella Vaccine Contributes to Its Attenuation.

Authors:  Tomohiko Sadaoka; Daniel P Depledge; Labchan Rajbhandari; Judith Breuer; Arun Venkatesan; Jeffrey I Cohen
Journal:  mBio       Date:  2022-08-02       Impact factor: 7.786

7.  Locked-nucleotide antagonists to varicella zoster virus small non-coding RNA block viral growth and have potential as an anti-viral therapy.

Authors:  Biswajit Das; Punam Bisht; Paul R Kinchington; Ronald S Goldstein
Journal:  Antiviral Res       Date:  2021-07-22       Impact factor: 10.103

8.  H84T BanLec has broad spectrum antiviral activity against human herpesviruses in cells, skin, and mice.

Authors:  M G Lloyd; D Liu; M Legendre; D M Markovitz; J F Moffat
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.996

Review 9.  The important role of non-covalent drug-protein interactions in drug hypersensitivity reactions.

Authors:  Werner J Pichler
Journal:  Allergy       Date:  2021-06-14       Impact factor: 14.710

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.